Perioperative Administration of Pregabalin for Pain After Robot-assisted Endoscopic Thyroidectomy

Study Overview
=================
Brief Summary
-----------------
The investigators hypothesize that pregabalin will decrease post-operative pain scores and analgesic use following robot-assisted endoscopic thyroidectomy compared to placebo. The primary outcome will be acute postoperative pain, measured by a verbal numerical rating score (VNRS) and total analgesic consumption during postoperative 48 hours. The secondary outcome will be the incidence of chronic pain and hypoesthesia in the anterior chest at 3 months after operation.

Official Title
-----------------
Perioperative Administration of Pregabalin for Pain After Robot-assisted Endoscopic Thyroidectomy

Conditions
-----------------
Pain, Postoperative

Intervention / Treatment
-----------------
* Drug: Pregabalin
* Drug: Vitamin Complex (placebo)


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: American Society of Anesthesia physical status class I & II Age ≥ 20 and ≤ 65 years Robot- assisted endoscopic thyroidectomy Exclusion Criteria: Known or suspected allergy, sensitivity, or contraindication to pregabalin or any of the standardized medications Body mass index ≥ 40 kg/m2 History of seizure disorder Current therapy with pregabalin, gabapentin, or any opioid Any other physical or psychiatric condition which may impair their ability to cooperate with post-operative study data collection Insulin-dependent diabetes mellitus Renal insufficiency (estimated glomerular filtration rate (eGFR) < 60 mL/min/1.73 m2)

Ages Eligible for Study
-----------------
Minimum Age: 20 Years
Maximum Age: 65 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Design Details

Primary Purpose: Treatment
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Triple


Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Placebo Comparator: Placebo<br>Patients receive oral Placebo 150 mg 1 hour prior to surgery, and 12 hours later | Drug: Vitamin Complex (placebo)<br>* Vitamin Complex 150 mg orally<br>|
| Experimental: Pregabalin<br>Patients receive oral pregabalin 150 mg 1 hour prior to surgery, and 12 hours later | Drug: Pregabalin<br>* Pregabalin 150 mg orally<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Pain Scores (VNRS) at 1, 6, 24, 48 Hours Postoperatively. | Pain was evaluated using an 11-point verbal numerical rating scale (VNRS). Patients were instructed preoperatively to express their pain on the 0-10 VNRS, where 0 means no pain at all, and 10 represents the worst pain imaginable | 1, 6, 24 & 48 hours | 
| The Number of Participants With the Indicated Side Effects - Nausea & Vomiting, Sedation, Headache, Dizziness Etc. | Nausea and vomiting was graded on a four-point scale, where 0 = no nausea, 1 = mild nausea, 2 = severe nausea requiring antiemetics, and 3 = retching and/ or vomiting. Grades 3 and 4 were grouped together as postoperative nausea and vomiting (PONV) and rescue anti-emetic, metoclopramide 10 mg i.v. was given. We asked patients about sedation, headache, dizziness, blurred vision. | 1, 6, 24 & 48 hours | 
| Number of Patients Who Required Additional Analgesics During the First 48 Hours Postoperatively |  | 1, 6, 24 & 48 hours | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Number of Patients With Hypoesthesia in the Anterior Chest at 3 Months After Operation. | we checked Hypoesthesia in the anterior chest at 3 months after operation by phone. | 3 months | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
thyroidectomy, pain, postoperative, pregabalin